Genetic Loss of Causes Adrenergic-Induced Phase 3 Early Afterdepolariz Ations and Polymorphic and Bidirectional Ventricular Tachycardia
Overview
Authors
Affiliations
Background: Arrhythmia syndromes associated with mutations have been described clinically; however, little is known of the underlying arrhythmia mechanism. We create the first patient inspired transgenic mouse and study effects of this mutation on cardiac function, , and Ca handling, to determine the underlying cellular arrhythmic pathogenesis.
Methods: A cardiac-specific -R67Q mouse was generated and bred for heterozygosity (R67Q). Echocardiography was performed at rest, under anesthesia. In vivo ECG recording and whole heart optical mapping of intact hearts was performed before and after adrenergic stimulation in wild-type (WT) littermate controls and R67Q mice. measurements, action potential characterization, and intracellular Ca imaging from isolated ventricular myocytes at baseline and after adrenergic stimulation were performed in WT and R67Q mice.
Results: R67Q mice (n=17) showed normal cardiac function, structure, and baseline electrical activity compared with WT (n=10). Following epinephrine and caffeine, only the R67Q mice had bidirectional ventricular tachycardia, ventricular tachycardia, frequent ventricular ectopy, and/or bigeminy and optical mapping demonstrated high prevalence of spontaneous and sustained ventricular arrhythmia. Both R67Q (n=8) and WT myocytes (n=9) demonstrated typical n-shaped relationship; however, following isoproterenol, max outward increased by ≈20% in WT but decreased by ≈24% in R67Q (<0.01). R67Q myocytes (n=5) demonstrated prolonged action potential duration at 90% repolarization and after 10 nmol/L isoproterenol compared with WT (n=7; <0.05). Ca transient amplitude, 50% decay rate, and sarcoplasmic reticulum Ca content were not different between WT (n=18) and R67Q (n=16) myocytes. R67Q myocytes (n=10) under adrenergic stimulation showed frequent spontaneous development of early afterdepolarizations that occurred at phase 3 of action potential repolarization.
Conclusions: mutation R67Q causes adrenergic-dependent loss of during terminal repolarization and vulnerability to phase 3 early afterdepolarizations. This model clarifies a heretofore unknown arrhythmia mechanism and extends our understanding of treatment implications for patients with mutation.
Kovacs Z, Horvath B, Dienes C, Ovari J, Kiss D, Hezso T Int J Mol Sci. 2024; 25(21).
PMID: 39519160 PMC: 11546480. DOI: 10.3390/ijms252111609.
Isolated Perfused Hearts for Cardiovascular Research: An Old Dog with New Tricks.
Yang T, Liu Z, Shu S, Chen Z, Hua X, Song J J Cardiovasc Transl Res. 2024; 17(5):1207-1217.
PMID: 38717725 PMC: 11519150. DOI: 10.1007/s12265-024-10517-7.
Wan Q, Lu Q, Luo S, Guan C, Zhang H Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):7273-7296.
PMID: 38709267 DOI: 10.1007/s00210-024-03142-3.
Acute Adenoviral Infection Elicits an Arrhythmogenic Substrate Prior to Myocarditis.
Padget R, Zeitz M, Blair G, Wu X, North M, Tanenbaum M Circ Res. 2024; 134(7):892-912.
PMID: 38415360 PMC: 11003857. DOI: 10.1161/CIRCRESAHA.122.322437.
Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome.
Moreno-Manuel A, Gutierrez L, Vera-Pedrosa M, Cruz F, Bermudez-Jimenez F, Martinez-Carrascoso I Cardiovasc Res. 2022; 119(4):919-932.
PMID: 35892314 PMC: 10153646. DOI: 10.1093/cvr/cvac118.